Brain Cancer News

“Avastin, both as a single agent and in combination with irinotecan chemotherapy, may improve survival compared to what would be normally expected for this devastating disease”

LOS ANGELES - Results from a mid-stage trial showed treatment with Genentech Inc's Avastin improved survival for patients with recurring brain cancer, the company said on Thursday.The Phase II trial compared ... via Reuters

Comment?

“The Avastin development program represents one of the most comprehensive undertakings in cancer research since the development of chemotherapy”

SOUTH SAN FRANCISCO, Calif. - Genentech, Inc. today provided an overview of several clinical studies of Avastin in multiple types of cancer that will be presented during the 44 th Annual Meeting of the American ... via Earth Times

Comment?

“Mother's Day is a great day to celebrate our child - ”

Sue McKechnie learned that her little boy, Shawn, had brain cancer on May 6, 2006. via The Toronto Star

Comment?

“We need to be able to discriminate between alterations that truly are mission-critical to the disease and those that are not”

Cancers will be much more effectively treated when physicians can determine all of the responsible genetic changes in a tumor and how they react and interact in response to specific treatment , according to one ... via MediLexicon

Comment?

Thallion Pharmaceuticals Inc. today announced it has received authorization from the Therapeutic Products Directorate of Health Canada to initiate a Phase II clinical trial evaluating TLN-4601 as a monotherapy ... via Market Wire

Comment?

It is huge medical news that you won't read about in the press, and it illustrates the power of Geron's first in man telomerase inhibitor. via Toledo Talk

Comment?

“During the quarter we continued to advance nimotuzumab globally, leveraging co-operative efforts of multiple partners and other licensees of the drug”

MISSISSAUGA, ON, May 8 /CNW/ - YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today reported operational and financial ... via Canada NewsWire

Comment?

TSX: BMR TORONTO, May 9 /CNW/ - Bradmer Pharmaceuticals Inc., a clinical oncology company specializing in the development and commercialization of cancer therapies, today announced its 2008 first quarter ... via Canada NewsWire

Comment?

“The jury is still out if this will translate into patients living longer, staying disease-free for a longer period of time. But we're all excited.”

Every year more than 21-thousand people in the U.S. are diagnosed with brain cancer. via KELO-TV Sioux Falls

Comment?

“The jury is still out if this will translate into patients living longer, staying disease-free for a longer period of time. But we're all excited”

Every two weeks, David Rose spends three hours at Mayo Clinic receiving chemotherapy for a brain tumor called a glioblastoma. via KAAL

2 comments